JAMA Author Interviews

JAMA Network

4.6 (162)
MEDICINE
UPDATED BIWEEKLY

Interviews with leading researchers and thinkers in health care about practice-changing research, innovations, and the most pressing issues facing medicine and health care today from JAMA, the Journal of the American Medical Association.

3 DAYS AGO

2024 Update on Long COVID Classification and Symptom List

Long COVID is now defined as a heterogeneous, infection-associated chronic condition present for at least 3 months after SARS-CoV-2 infection. Author Leora Horwitz, MD, MHS, of NYU Grossman School of Medicine joins JAMA Executive Editor Gregory Curfman, MD, to discuss the JAMA article "2024 Update of the RECOVER-Adult Long COVID Research Index." Related Content: 2024 Update of the RECOVER-Adult Long COVID Research Index Characterizing Long COVID in Children and Adolescents

12 min
DEC 13

Camrelizumab vs Placebo With Chemotherapy as Neoadjuvant Treatment in Triple-Negative Breast Cancer

Triple-negative breast cancer accounts for around 15% of breast cancers. Zhi-Ming Shao, MD, of Fudon University, joins JAMA Oncology Editor in Chief and JAMA Deputy Editor Nora Disis, MD, to discuss "Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients with Early or Locally Advanced Triple-Negative Breast Cancer: The CamRelief Randomized Clinical Trial." Related Content: Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer

15 min
DEC 1

HIV Treatment and Prevention: Updated Recommendations

New antiretroviral drugs and formulations continue to become available for the prevention and management of HIV infection. Author Rajesh T. Gandhi, MD, joins JAMA Deputy Editor Preeti Malani, MD, MSJ, to discuss these new approaches for HIV. Related Content: Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel Advances in Treatment and Prevention of HIV

15 min
NOV 25

The Impacts of Severe Maternal Morbidity

A new JAMA study examines the association between severe maternal morbidity in a first birth and the probability of a subsequent birth. Authors Neda Razaz, PhD, and Eleni Tsamantioti, MD, MMedSc, both from the Karolinska Institute in Sweden, discuss this and more with JAMA Associate Editor Melissa A. Simon, MD, MPH. Related Content: Association of Severe Maternal Morbidity With Subsequent Birth Severe Maternal Morbidity and Subsequent Birth—Understanding and Informing a Woman’s Choice

13 min
NOV 18

Zerlasiran, a Small-Interfering RNA That Targets Lipoprotein(a)

Elevated lipoprotein(a) levels increase the risk of atherosclerotic cardiovascular disease (ASCVD) and aortic stenosis. Cleveland Clinic’s Steven E. Nissen, MD, speaks with JAMA Executive Editor Gregory Curfman, MD, about how zerlasiran produced more than 80% reductions in time-averaged lipoprotein(a) concentration. Related Content: Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a)

14 min
NOV 11

Intratracheal Budesonide for Extremely Preterm Infants

Preterm birth is the greatest cause of neonatal mortality and morbidity, with infants born extremely preterm at highest risk. Author Brett J. Manley, PhD, the Royal Women’s Hospital, Melbourne, Australia, discusses a new study of the effect of intratracheal corticosteroid administration on survival free of bronchopulmonary dysplasia in preterm infants, with JAMA Deputy Editor Tracy A. Lieu, MD, MPH. Related Content: Intratracheal Budesonide Mixed With Surfactant for Extremely Preterm Infants

8 min
NOV 3

Digital Health Behavior Intervention to Prevent Childhood Obesity

Preventing obesity in early childhood is challenging for clinicians and families. Authors Eliana M. Perrin, MD, MPH, of Johns Hopkins University, and William J. Heerman, MD, MPH, of Vanderbilt University, join JAMA Deputy Editor Tracy Lieu, MD, to discuss "A Digital Health Behavior Intervention to Prevent Childhood Obesity: The Greenlight Plus Randomized Clinical Trial." Related Content: A Digital Health Behavior Intervention to Prevent Childhood Obesity

13 min
OCT 31

Drug Shortages After Supply Chain Issues in the US vs Canada

A new study published in JAMA found that drug-related supply chain issue reports were 40% less likely to result in meaningful drug shortages in Canada compared with the US. Authors Kate Suda, PharmD, MS, of University of Pittsburgh School of Medicine, and Mina Tadrous, PharmD, PhD, of University of Toronto, discuss this and more with JAMA Deputy Editor Joseph S. Ross, MD, MHS. Related Content: Differences in Drug Shortages in the US and Canada Understanding Drug Supply Shortages in the US and Canada

12 min

See All (839)

4.6

out of 5

162 Ratings

One of the best interviewers

07/27/2021

Rose_Marie_Holt

It's an art to interview the variety of people "in COVID" some of whom may not have the best intentions or information but need to be heard & some of whom may need some structure to communicate their information well to non specialists or lay people. I'm so glad Dr Bauchner is still doing these interviews. The best for hearing all important viewpoints well & excellent information from primary sources. I still use some of these interview as key sources for COVID discussions.
Interesting podcasts

04/18/2021

KML355

I am a retired pharmacist and I started tuning in after my daughter’s physician mentioned he listened to them. I wanted to get accurate information on COVID 19. Dr. Bauchner is an excellent interviewer gathering his own questions as well as those of the listeners. He has a good sense of humor which makes the podcasts even better.
Excellent podcast

03/12/2021

Smiley Med Man

This is really an excellent podcast, specially for physicians who are interested in various aspects of healthcare. I subscribe to JAMA and so I do have access to the published articles. But this podcast selects the more important recent article/articles and goes much beyond the written article with an interview with the author or authors to discuss its real significance in healthcare. Dr. Bauchner is excellent in his role as a very knowledgeable host asking the most pertinent questions, and the guests are, of course, ideally qualified to discuss that particular subject. The podcasts are technically well produced with great rhythm and sound quality, and pleasant to hear. Really want to thank AMA and Dr. Bauchner for doing a great public service.
Great topics and guests

12/05/2020

Rachel H 10

This is the best place to get accurate information about Covid and other medical issues. Love this podcast!

Interviews with leading researchers and thinkers in health care about practice-changing research, innovations, and the most pressing issues facing medicine and health care today from JAMA, the Journal of the American Medical Association.